Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bernhard

Showing results (141-150 of 250) with videos related to

Pageof 25
Sort By:
Translational Cancer Research|August 7, 2012
Normal tissue protection for improving radiotherapy: Where are the Gaps?Pataje G S Prasanna, Helen B Stone, Rosemary S Wong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2001
Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groupsG Kiebert, S Wait, J Bernhard, et al.
International Journal of Radiation Biology|October 8, 2003
Farnesyltransferase inhibitors as radiation sensitizersT B Brunner, A K Gupta, Y Shi, et al.
Cancer Research|May 1, 1998
Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenesE J Bernhard, W G McKenna, A D Hamilton, et al.
Onkologie|May 15, 2002
Socio-demographic and medical characteristics of advanced cancer patients using conventional or complementary medicineS Pampallona, E Von Rohr, B Van Wegberg, et al.
Cancer Research|May 19, 2001
The Ras radiation resistance pathwayA K Gupta, V J Bakanauskas, G J Cerniglia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificityE J Bernhard, A X Le, J R Yannelli, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Evaluation of halobetasol propionate ointment in the treatment of plaque psoriasis: report on two double-blind, vehicle-controlled studiesJ Bernhard, C Whitmore, C Guzzo, et al.
Cancer Research|July 23, 2009
Tumor vascular changes mediated by inhibition of oncogenic signalingNaseer Qayum, Ruth J Muschel, Jae Hong Im, et al.
The Prostate|September 25, 2004
Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survivalYuquan Shi, Junmin Wu, Rosemarie Mick, et al.
Pageof 25

Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
Translational Cancer Research|August 7, 2012
Normal tissue protection for improving radiotherapy: Where are the Gaps?Pataje G S Prasanna, Helen B Stone, Rosemary S Wong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2001
Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groupsG Kiebert, S Wait, J Bernhard, et al.
International Journal of Radiation Biology|October 8, 2003
Farnesyltransferase inhibitors as radiation sensitizersT B Brunner, A K Gupta, Y Shi, et al.
Cancer Research|May 1, 1998
Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenesE J Bernhard, W G McKenna, A D Hamilton, et al.
Onkologie|May 15, 2002
Socio-demographic and medical characteristics of advanced cancer patients using conventional or complementary medicineS Pampallona, E Von Rohr, B Van Wegberg, et al.
Cancer Research|May 19, 2001
The Ras radiation resistance pathwayA K Gupta, V J Bakanauskas, G J Cerniglia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificityE J Bernhard, A X Le, J R Yannelli, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Evaluation of halobetasol propionate ointment in the treatment of plaque psoriasis: report on two double-blind, vehicle-controlled studiesJ Bernhard, C Whitmore, C Guzzo, et al.
Cancer Research|July 23, 2009
Tumor vascular changes mediated by inhibition of oncogenic signalingNaseer Qayum, Ruth J Muschel, Jae Hong Im, et al.
The Prostate|September 25, 2004
Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survivalYuquan Shi, Junmin Wu, Rosemarie Mick, et al.
Pageof 25